UBS Asset Management’s report highlights the strategic criteria for selecting European cities best positioned for life sciences real estate investment.
-
Ecosystem drivers: Strong universities, interdisciplinary talent pools, and access to financing underpin sustainable life sciences clusters.
-
Key hubs: The UK’s “Golden Triangle” (Oxford, Cambridge, London), Paris, and the Randstad lead, with Berlin and Barcelona emerging as rising centres.
-
Geopolitical shifts: Tariffs could alter location strategies, with Dublin exposed due to heavy U.S. export reliance, while adaptable clusters stand to benefit.
Which European hubs offer the strongest long-term resilience for LSRE investors? The full report explores the opportunities.
.
Om dit artikel te lezen heeft u een abonnement op Investment Officer nodig. Heeft u nog geen abonnement, klik op "Abonneren" voor de verschillende abonnementsregelingen.
